| IFX Stock | | | CAD 1.49 0.02 1.36% |
VP
Dr. Ralf Dujardin, Ph.D., is Vice President Marketing and Innovation of Imaflex Inc., with effect from July 1, 2013. Dr. Dujardin joins Imaflex after spending 26 years within the Bayer organization. Dr. Dujardin started his career with Bayer in 1986 as a polymer chemist. He was most recently Portfolio Manager and Senior Project Manager at Bayer Innovation GmbH in Germany. In this role, he was responsible for strategically building a portfolio of innovative products and intellectual property, which included active ingredient equipped plastics for the agriculture market. Prior to this role, Dr. Dujardin was Vice President Corporationrationrate Venturing and Business Development, where he managed a fund of approximately 25 million in selected material and life science investments since 2013.
| Tenure | 11 years |
| Professional Marks | Ph.D |
| Address | 5710 Notre Dame Street West, Montreal, QC, Canada, H4C 1V2 |
| Phone | 514 935 5710 |
| Web | https://www.imaflex.com |
Dujardin completed his PhD in Chemistry at the University of Siegen in Germany in 1986.
Imaflex Management Efficiency
The company has return on total asset
(ROA) of
0.051 % which means that it generated a profit of $0.051 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0749 %, meaning that it generated $0.0749 on every $100 dollars invested by stockholders. Imaflex's management efficiency ratios could be used to measure how well Imaflex manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to 0.01 in 2024.
Return On Capital Employed is likely to drop to 0.04 in 2024. At this time, Imaflex's
Total Assets are fairly stable compared to the past year.
Non Current Assets Total is likely to climb to about 57.8
M in 2024, whereas
Net Tangible Assets are likely to drop slightly above 30.7
M in 2024.
Imaflex has accumulated 11.41
M in total debt with debt to equity ratio
(D/E) of 60.9, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Imaflex has a current ratio of 1.55, which is within standard range for the sector. Debt can assist Imaflex until it has trouble settling it off, either with new capital or with free cash flow. So, Imaflex's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Imaflex sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Imaflex to invest in growth at high rates of return. When we think about Imaflex's use of debt, we should always consider it together with cash and equity.
Imaflex Inc., together with its subsidiary, develops, manufactures, and sells flexible packaging materials for consumer, industrial, and agriculture markets in Canada, the United States, and internationally. The company was founded in 1994 and is headquartered in Montreal, Canada. IMAFLEX INC operates under Packaging Containers classification in Canada and is traded on TSX Venture Exchange. It employs 252 people. Imaflex (IFX) is traded on TSX Venture Exchange in Canada and employs 268 people. Imaflex is listed under Paper & Plastic Packaging Products & Materials category by Fama And French industry classification.
Management Performance
Imaflex Leadership Team
Elected by the shareholders, the Imaflex's board of directors comprises two types of representatives: Imaflex inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Imaflex. The board's role is to monitor Imaflex's management team and ensure that shareholders' interests are well served. Imaflex's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Imaflex's outside directors are responsible for providing unbiased perspectives on the board's policies.
Imaflex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Imaflex a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Imaflex Stock Analysis
When running Imaflex's price analysis, check to
measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to
predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.